This clinical trial studies how well a breast cancer locator works in detecting the location of breast cancer in patients with cancer that can be felt by touch. Breast cancer locators may accurately localize breast cancer and may be a useful guide for surgeons to remove the cancer.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT02550210.
PRIMARY OBJECTIVES
I. To measure the distance from the center of the spots made by the breast cancer locator (BCL) to the cancer edges.
SECONDARY OBJECTIVES:
I. To determine the pathologic final margin (distance from the tumor to the specimen edge).
II. To determine the difference between the medial, lateral, cranial and caudal tumor edges as defined by the BCL and the supine magnetic resonance (MR)/optical scan/tracker system.
III. To determine lumpectomy specimen volumes.
OUTLINE:
Patients undergo magnetic resonance imaging (MRI) over 45 minutes and an optical scan over 5 minutes prior to surgery. Patients also undergo placement of the BCL at the time of surgery.
Trial PhaseNo phase specified
Trial Typetreatment
Lead OrganizationDartmouth Hitchcock Medical Center/Dartmouth Cancer Center
Principal InvestigatorRichard J. Barth
